Spherix Global Insights
Advertising Networks · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
760 Constitution Dr Ste 204, Exton, Penn...Phone Number
(484) 879-4284Revenue
$15.4 MillionIndustry
About Spherix Global Insights
Spherix Global Insights Org Chart
Is Spherix Global Insights your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Spherix Global Insights has new funding data
Check out if Spherix Global Insights is spiking on competitors!
Product Launch: Get notified when Spherix Global Insights launches new products
Click to see if Spherix Global Insights had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Spherix Global Insights, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Spherix Global Insights has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Spherix Global Insights
Earning: See what the market has to say on Spherix Global Insights recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Spherix Global Insights
Compare insights from companies similar to Spherix Global Insights, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Spherix Global Insights is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Spherix Global Insights is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Spherix Global Insights.
Spherix Global Insights Tech Stack
A closer look at the technologies used by Spherix Global Insights
Most Recent Scoops
Spherix Global Insights News & Media
Brepocitinib Interest Gains Momentum in Idiopathic Inflammatory Myopathies as Rheumatologists Signal Readiness for Targeted, Steroid-Sparing Therapies
Spherix Global Insights highlights rising enthusiasm for Priovant’s TYK2/JAK1 inhibitor alongside continued dissatisfaction with current treatment approaches in dermatomyositis and polymyositis. Spherix Global Insights highlights rising enthusiasm for Priovant’s TYK2/JAK1 inhibitor alongside continued dissatisfaction with current treatment approaches in dermatomyositis and polymyositis.Eli Lilly’s Oral GLP-1 Foundayo Trails Novo Nordisk’s Wegovy Pill in Early Obesity Launch Uptake, According to Spherix Global Insights
Despite a more flexible administration profile, Foundayo generated lower first-month prescribing rates than the Wegovy Pill among both primary care physicians (PCPs) and endocrinologists. Despite a more flexible administration profile, Foundayo generated lower first-month prescribing rates than the Wegovy Pill among both primary care physicians (PCPs) and endocrinologists.Real-World CAR-T Delays in LBCL Drive Reliance on Bridging Therapy, According to Spherix Global Insights
Analysis of 187 audited patient charts reveals persistent operational barriers remain common for patients with large B-cell lymphoma (LBCL), reinforcing the role of targeted therapies during the CAR-T treatment journey Analysis of 187 audited patient charts reveals persistent operational barriers remain common for patients with large B-cell lymphoma (LBCL), reinforcing the role of targeted therapies during the CAR-T treatment journeySotyktu’s Psoriatic Arthritis Launch Builds Gradually in Month Two as Rheumatologists Continue to Take Measured Approach to TYK2 Adoption, According to Spherix Global Insights
Despite incremental gains in awareness and prescribing, most launch metrics continue to trail recent rheumatology benchmarks, underscoring both the challenges and strategic importance of the first TYK2 inhibitor launch in rheumatology. Despite incremental gains in awareness and prescribing, most launch metrics continue to trail recent rheumatology benchmarks, underscoring both the challenges and strategic importance of the first TYK2 inhibitor launch in rheumatology.
Top Advertising Networks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Spherix Global Insights
Spherix Global Insights is a hyper-focused market intelligence firm that leverages the company's own independent data and expertise to provide strategic guidance, so biopharma stakeholders make decisions with confidence. The company specializes in select dermatology, gastroenterology, nephrology, neurology, and rheumatology markets.... Read More
